Effects of the p38 MAPK inhibitor, SB203580, on morphological disruption and cell death of zinc-treated C6 glioma and NIH3T3 cells
Assays were performed 24 hrs after Zn2+ treatment. SB203580 was applied to cultures 1 h before Zn2+ treatment. *SB203580 concentration was 20 µM.